Marijuana Rescheduling and DOT Drug Testing: What Has Actually Changed?

By ECP Clinical Editorial

Headlines about marijuana rescheduling have created understandable confusion for transportation employers, CDL drivers, and other safety-sensitive workers.

Does a federal scheduling change mean marijuana will be removed from DOT drug testing? Does a state-issued medical-marijuana card protect an employee after a positive test? Should employers update their testing policies?

As of September 2026, the practical answer for DOT-regulated employers is straightforward: DOT drug-testing requirements have not changed.

Rescheduling Is Not the Same as Legalization

Federal discussions about moving marijuana from Schedule I to Schedule III have received significant attention. However, rescheduling and legalization are not the same.

As of September 2026, the Drug Enforcement Administration continues to list marijuana as a Schedule I controlled substance. A proposal, hearing, or public discussion does not change federal law until the required rulemaking process is completed and a final rule becomes effective.

Even if marijuana is eventually placed in another schedule, that action would not automatically:

• Legalize recreational marijuana federally

• Remove marijuana from the DOT testing panel

• Permit safety-sensitive employees to use marijuana

• Require an employer to accept a state medical-marijuana card

• Change an existing positive DOT test result

  
  

Controlled-substance scheduling and DOT drug-testing requirements operate under separate federal frameworks.

DOT Testing Still Includes Marijuana

DOT-regulated drug testing continues to test for marijuana metabolites. The current federal testing standard lists marijuana metabolite testing with established initial and confirmatory cutoff concentrations.

This applies to DOT-regulated safety-sensitive workers, including many commercial motor vehicle drivers.

Until the Department of Transportation formally changes its regulations or issues new binding requirements, employers and employees should continue following the existing testing program.

Does a Medical-Marijuana Card Explain a Positive DOT Test?

A state medical-marijuana authorization does not automatically provide a legitimate medical explanation for a positive DOT drug test.

Under DOT rules, a Medical Review Officer evaluates whether a confirmed positive result has a legitimate medical explanation. A state authorization to obtain marijuana does not make the product an FDA-approved prescription medication under federal law.

Therefore, employees should not assume that living in a state where medical or recreational marijuana is permitted will protect them from the consequences of a verified positive DOT test.

State legality and DOT compliance are separate issues.

What Happens After a Verified Positive Test?

A verified positive DOT drug test carries specific federal consequences. The employee must be removed from DOT safety-sensitive functions and cannot return to those duties until the applicable return-to-duty process has been completed.

That process generally includes:

• Evaluation by a qualified Substance Abuse Professional

• Completion of the recommended education or treatment plan

• A successful return-to-duty test

• Follow-up testing as directed

  
  

An employer should not disregard, change, or reinterpret a result reported by the Medical Review Officer.

What Should Employers Do Now?

Employers do not need to redesign their DOT testing programs in response to marijuana-rescheduling headlines.

Instead, they should:

Continue following current DOT regulations

Marijuana remains part of the federal testing panel. Continue using qualified collection sites, laboratories, Medical Review Officers, and consortium or third-party administrators as applicable.

Keep DOT and non-DOT policies separate

An organization may have both DOT-regulated employees and employees covered only by company policy. State laws may affect non-DOT workplace testing differently, but they do not replace federal requirements for DOT-regulated positions.

Policies and testing orders should clearly identify whether a test is DOT or non-DOT.

Communicate clearly with employees

Employees should understand that marijuana use permitted under state law may still result in a positive federal drug test and removal from safety-sensitive duties.

This information should be addressed during onboarding, policy training, and periodic safety communication—not introduced for the first time after a positive result.

Avoid making changes based on headlines alone

Employers should wait for official guidance from the Department of Transportation before changing testing panels, policies, or procedures.

A federal scheduling announcement does not automatically revise DOT testing requirements.

The Bottom Line

Marijuana policy continues to evolve, but the rules governing DOT-regulated drug testing remain in place.

For transportation employers and safety-sensitive employees:

• Marijuana remains on the DOT testing panel.

• State legalization does not override federal DOT requirements.

• A medical-marijuana card does not automatically excuse a positive DOT test.

• Employers should continue following existing testing and return-to-duty procedures.

• Policies should be updated only when supported by official regulatory changes.

  
  

Elite Clinical Partners supports employers with DOT and non-DOT drug-testing coordination, occupational health services, and practical workforce-compliance processes.

Learn more at ecp-health.com.

Sources: DEA Drug Scheduling, DOT Part 40 §40.85, and DOT Part 40 §40.137.